T1	Participants 88 128	non-insulin dependent diabetes mellitus.
T2	Participants 249 389	30 non-insulin dependent (Type II) diabetic subjects during a 3-week observation period (run-in/drug; placebo/wash-out) on a metabolic ward.
T3	Participants 1300 1316	Type II diabetic
